Prof Therese Kinsella, founder and chief executive of Atxa Therapeutics. Photograph: Vincent Hoban

UCD spinout drug company Atxa Therapeutics, which is developing novel therapies that tackle a deadly heart condition, is seeking to raise $30 million (...)